Nasdaq
$1.11▼ 0.45%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $712.1MShares out 6.400M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
5- 10.1After-hours26.10.02 05:304Ownership#●●●#●●●
GERON CORP
Geron Corp insider Robert J. Spiegel filed a Form 4 report regarding changes in beneficial ownership of securities as of September 30, 2026. This filing serves as a standard disclosure of the insider's equity position adjustments.…more
$1.11-0.45%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 8.7Regular26.08.07 22:41SCHEDULE 13GOwnership
GERON CORP
State Street Corp이 Geron Corp의 지분 5% 이상을 보유한 대량보유자임을 공시했습니다. 이번 Schedule 13G 제출은 기관 투자자의 지분 변동에 따른 의무적인 보고 사항입니다.…more
$1.11-0.45%vs prev closeView filingShare - 8.6Pre-market26.08.06 19:058-KKey event
GERON CORP
제론(Geron)은 2026년 2분기 RYTELO 순매출 5,750만 달러를 기록하며 전 분기 대비 11% 성장했고, 3억 2,700만 달러의 현금 및 유동 자산을 보유하고 있다고 발표했습니다. 2026년 연간 RYTELO 순매출 가이던스는 2억 2,000만~2억 4,000만 달러, 총 영업비용은 2억 3,000만~2억 4,000만 달러로 유지했습니다.…more
$1.11-0.45%vs prev closeView filingShare
4 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 4d agoPre-market26.10.21 21:00#●●●#●●●
Geron to Announce Q3 2026 Financial Results on November 4
Geron Corporation will release its third quarter 2026 financial results and business highlights before the market opens on November 4, 2026. The company will also host a conference call and webcast to discuss the results.…more
$1.11-0.45%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 5d agoAfter-hours26.10.20 05:01
●●●●●●●● ●●●●● ●●●●●●
Geron Corporation announced the grant of stock options for 570,000 shares to three new employees as an employment inducement. This is a standard compensation practice for talent acquisition and does not represent a material change in corporate value.…more
$1.11-0.45%vs prev close - 10.12Pre-market26.10.12 21:03
●●●●●●●● ●●●●● ●●●●●●
Geron Corporation announced oral and poster presentations highlighting clinical and real-world evidence for imetelstat in patients with lower-risk myelodysplastic syndromes at major hematology meetings in Europe and Asia. These presentations aim to reinforce the drug's efficacy and safety profile while expanding global scientific engagement.…more
$1.11-0.45%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report